Sarah E Wakeman1,2, Joshua P Metlay3,4, Yuchiao Chang3,4, Grace E Herman5, Nancy A Rigotti3,4. 1. Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA. swakeman@partners.org. 2. Harvard Medical School, Boston, MA, USA. swakeman@partners.org. 3. Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, USA. 4. Harvard Medical School, Boston, MA, USA. 5. Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
Abstract
BACKGROUND: Alcohol and drug use results in substantial morbidity, mortality, and cost. Individuals with alcohol and drug use disorders are overrepresented in general medical settings. Hospital-based interventions offer an opportunity to engage with a vulnerable population that may not otherwise seek treatment. OBJECTIVE: To determine whether inpatient addiction consultation improves substance use outcomes 1 month after discharge. DESIGN: Prospective quasi-experimental evaluation comparing 30-day post-discharge outcomes between participants who were and were not seen by an addiction consult team during hospitalization at an urban academic hospital. PARTICIPANTS: Three hundred ninety-nine hospitalized adults who screened as high risk for having an alcohol or drug use disorder or who were clinically identified by the primary nurse as having a substance use disorder. INTERVENTION: Addiction consultation from a multidisciplinary specialty team offering pharmacotherapy initiation, motivational counseling, treatment planning, and direct linkage to ongoing addiction treatment. MAIN MEASURES: Addiction Severity Index (ASI) composite score for alcohol and drug use and self-reported abstinence at 30 days post-discharge. Secondary outcomes included 90-day substance use measures and self-reported hospital and ED utilization. KEY RESULTS: Among 265 participants with 30-day follow-up, a greater reduction in the ASI composite score for drug or alcohol use was seen in the intervention group than in the control group (mean ASI-alcohol decreased by 0.24 vs. 0.08, p < 0.001; mean ASI-drug decreased by 0.05 vs. 0.02, p = 0.003.) There was also a greater increase in the number of days of abstinence in the intervention group versus the control group (+12.7 days vs. +5.6, p < 0.001). The differences in ASI-alcohol, ASI-drug, and days abstinent all remained statistically significant after controlling for age, gender, employment status, smoking status, and baseline addiction severity (p = 0.018, 0.018, and 0.02, respectively). In a sensitivity analysis, assuming that patients who were lost to follow-up had no change from baseline severity, the differences remained statistically significant. CONCLUSIONS: In a non-randomized cohort of medical inpatients, addiction consultation reduced addiction severity for alcohol and drug use and increased the number of days of abstinence in the first month after hospital discharge.
BACKGROUND:Alcohol and drug use results in substantial morbidity, mortality, and cost. Individuals with alcohol and drug use disorders are overrepresented in general medical settings. Hospital-based interventions offer an opportunity to engage with a vulnerable population that may not otherwise seek treatment. OBJECTIVE: To determine whether inpatient addiction consultation improves substance use outcomes 1 month after discharge. DESIGN: Prospective quasi-experimental evaluation comparing 30-day post-discharge outcomes between participants who were and were not seen by an addiction consult team during hospitalization at an urban academic hospital. PARTICIPANTS: Three hundred ninety-nine hospitalized adults who screened as high risk for having an alcohol or drug use disorder or who were clinically identified by the primary nurse as having a substance use disorder. INTERVENTION: Addiction consultation from a multidisciplinary specialty team offering pharmacotherapy initiation, motivational counseling, treatment planning, and direct linkage to ongoing addiction treatment. MAIN MEASURES: Addiction Severity Index (ASI) composite score for alcohol and drug use and self-reported abstinence at 30 days post-discharge. Secondary outcomes included 90-day substance use measures and self-reported hospital and ED utilization. KEY RESULTS: Among 265 participants with 30-day follow-up, a greater reduction in the ASI composite score for drug or alcohol use was seen in the intervention group than in the control group (mean ASI-alcohol decreased by 0.24 vs. 0.08, p < 0.001; mean ASI-drug decreased by 0.05 vs. 0.02, p = 0.003.) There was also a greater increase in the number of days of abstinence in the intervention group versus the control group (+12.7 days vs. +5.6, p < 0.001). The differences in ASI-alcohol, ASI-drug, and days abstinent all remained statistically significant after controlling for age, gender, employment status, smoking status, and baseline addiction severity (p = 0.018, 0.018, and 0.02, respectively). In a sensitivity analysis, assuming that patients who were lost to follow-up had no change from baseline severity, the differences remained statistically significant. CONCLUSIONS: In a non-randomized cohort of medical inpatients, addiction consultation reduced addiction severity for alcohol and drug use and increased the number of days of abstinence in the first month after hospital discharge.
Authors: Nancy A Rigotti; Susan Regan; Douglas E Levy; Sandra Japuntich; Yuchiao Chang; Elyse R Park; Joseph C Viana; Jennifer H K Kelley; Michele Reyen; Daniel E Singer Journal: JAMA Date: 2014-08-20 Impact factor: 56.272
Authors: Gail D'Onofrio; Patrick G O'Connor; Michael V Pantalon; Marek C Chawarski; Susan H Busch; Patricia H Owens; Steven L Bernstein; David A Fiellin Journal: JAMA Date: 2015-04-28 Impact factor: 56.272
Authors: Peter Roy-Byrne; Kristin Bumgardner; Antoinette Krupski; Chris Dunn; Richard Ries; Dennis Donovan; Imara I West; Charles Maynard; David C Atkins; Meredith C Graves; Jutta M Joesch; Gary A Zarkin Journal: JAMA Date: 2014-08-06 Impact factor: 56.272
Authors: Anna Pecoraro; Terry Horton; Edward Ewen; Julie Becher; Patricia A Wright; Basha Silverman; Patty McGraw; George E Woody Journal: Addict Sci Clin Pract Date: 2012-09-25
Authors: Paul J Joudrey; Benjamin J Oldfield; Kimberly A Yonkers; Patrick G O'Connor; Gretchen Berland; E Jennifer Edelman Journal: Drug Alcohol Depend Date: 2020-06-02 Impact factor: 4.492
Authors: Steve Martino; Paula Zimbrean; Ariadna Forray; Joy S Kaufman; Paul H Desan; Todd A Olmstead; Kathryn Gilstad-Hayden; Ralitza Gueorguieva; Kimberly A Yonkers Journal: J Gen Intern Med Date: 2019-08-29 Impact factor: 5.128
Authors: Alysse G Wurcel; Griffin Boll; Deirdre Burke; Rani Khetarpal; Patrick J Warner; Alice M Tang; Kenneth G Warner Journal: Ann Thorac Surg Date: 2019-10-17 Impact factor: 4.330
Authors: Joji Suzuki; Jennifer A Johnson; Mary W Montgomery; Margaret C Hayden; Christin N Price; Daniel A Solomon; Jane M Liebschutz; Jeffrey L Schnipper; Roger D Weiss Journal: J Addict Med Date: 2020 Jul/Aug Impact factor: 3.702
Authors: Courtney D Nordeck; Christopher Welsh; Robert P Schwartz; Shannon Gwin Mitchell; Art Cohen; Kevin E O'Grady; Jan Gryczynski Journal: Drug Alcohol Depend Date: 2018-03-02 Impact factor: 4.492
Authors: Maria J D'Amico; Alexander Y Walley; Debbie M Cheng; Leah S Forman; Danny Regan; Alexandra Yurkovic; Jeffrey H Samet; Zoe M Weinstein Journal: J Subst Abuse Treat Date: 2019-08-20